Addex Therapeutics
ADXN
7,38 €
Share price
3.32%
Change (1 day)
-0.37%
Change (1 year)
Categories
Revenue for Addex Therapeutics (ADXN)
Revenue in 2025 (TTM): €0.17 Million
According to Addex Therapeutics's latest financial reports the company's current revenue (TTM 
) is €0.16 Million. In 2024 the company made a revenue of €0.43 Million a decrease over the revenue in the year 2023 that were of €1.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Addex Therapeutics from 2019 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | €0.17 M | -59.03% |
| 2024 | €0.43 M | -73.18% |
| 2023 | €1.62 M | 15.45% |
| 2022 | €1.4 M | -49.28% |
| 2021 | €2.76 M | -13.71% |
| 2020 | €3.2 M | 27.74% |
| 2019 | €2.51 M |